Cardiovascular diseases, formerly only attributed to the alterations of the stromal component, are now recognized as immune-based pathologies. Plasmacytoid Dendritic Cells (pDCs) are important immune orchestrators in heart and vessels. They highly produce IFN type I that promote the polarization of T cells towards a Th1 phenotype; however, pDCs can also participate to suppressive networks via the recruitment of T regulatory cells that downmodulate proinflammatory responses. pDCs populate the vessel wall layers during pathological conditions, such as atherosclerosis. It is thus clear that a better identification of pDCs activity in cardiovascular diseases can not only elucidate pathological mechanisms but also lead to new therapeutic approaches. © 2010 Rosalinda Sorrentino et al.
CITATION STYLE
Sorrentino, R., Morello, S., & Pinto, A. (2010). Plasmacytoid dendritic cells: From heart to vessels. International Journal of Vascular Medicine. Hindawi Publishing Corporation. https://doi.org/10.1155/2010/430318
Mendeley helps you to discover research relevant for your work.